Search
for
Sort by
Research 61–90 of 165
- Estrogens and aging skin
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Oestrogen functions in skin and skin appendages
- The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration
- Emerging nonmetabolic functions of skin fat
- Hirsutism and the Variable Response of the Pilosebaceous Unit to Androgen
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- 5α-Reduced glucocorticoids: a story of natural selection
- Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne
- Analysis of 1,25-Dihydroxyvitamin D3 Receptors (VDR. in Basal Cell Carcinomas
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Establishment of SV40T-transformed human dermal papilla cells and identification of dihydrotestosterone-regulated genes by cDNA microarray
- Proteomic analysis of balding and non-balding mesenchyme-derived dermal papilla cells from androgenetic alopecia patients using on-line two-dimensional reversed phase-reversed phase LC–MS/MS
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Androgen receptor CAG repeat length is associated with ovarian reserve but not with ovarian response
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Down-RANKing the Threat of HSV-1: RANKL Upregulates MHC-Class-I-Restricted Anti-Viral Immunity in Herpes Simplex Virus Infection
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- A computationally inferred regulatory heart aging model including post-transcriptional regulations
- Epithelial–mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy
- α-Mangostin, a safe and natural product as a candidate skin-whitening agent
- Clinical-Exome Sequencing Unveils the Genetic Landscape of Polycystic Ovarian Syndrome (PCOS) Focusing on Lean and Obese Phenotypes: Implications for Cost-Effective Diagnosis and Personalized Treatment
- Biotin - facts and hopes
- Modelling androgen synthesis and action during human sexual differentiation
- Anabolic-androgenic steroids and cardiovascular risk
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers